ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1,150 Cr | ₹2,101 Cr | ₹979 Cr | ₹730 Cr | ₹-79 Cr |
What is the latest Total Non-Current Liabilities ratio of ERIS LIFESCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹1,150 Cr |
| Mar2025 | ₹2,101 Cr |
| Mar2024 | ₹979 Cr |
| Mar2023 | ₹730 Cr |
| Mar2022 | ₹-79 Cr |
How is Total Non-Current Liabilities of ERIS LIFESCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,150 Cr | -45.27 | |
| Mar2025 | ₹2,101 Cr | 114.53 | |
| Mar2024 | ₹979 Cr | 34.15 | |
| Mar2023 | ₹730 Cr | Positive | |
| Mar2022 | ₹-79 Cr | - | |
Compare Total Non-Current Liabilities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹17,678.0 Cr | -3.5% | -2.7% | -22.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -3.5% |
-2.7% |
-22.5% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses